Scholars Central

Conference abstractPublished 11 Jun 2018

Decrease in CoQ by statin treatment does not attenuate exercise-induced adaptations in the myocardium

Authors: Joseph W Starnes, Bryan J Feger

University of North Carolina at Greensboro, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background & Aim: A side effect of cholesterol lowering statins is lowered coenzyme Q (CoQ), a component of the mitochondrial Electron Transport Chain (ETC) with antioxidant properties. Many statin patients take a CoQ supplement to counter CoQ lowering. Is this necessary? The ETC CoQ content is far greater than all other electron carriers. The purpose of this study was to test the hypothesis that the decrease in CoQ associated with high-dose statin treatment is not sufficient to affect cardiac function or the ability of the heart to adapt to exercise training. Methodology: Female S-D rats were divided into four groups (8-10/group): sedentary (S), S+Simvastatin (S+ST) (10 mg/kg/ day orally), exercised on a treadmill for 5 days/wk up a 6Ã?° incline for 5 weeks (E) or E+ST. By week 5 animals were running 1 hr at 30 m/min (approximately 80% Vo2max). Twenty-four hours after the last session, myocardial hemodynamic performance and oxygen consumption was evaluated using an isolated perfused working heart system. After storage at -80Ã?°C, ventricular oxidized and reduced COQ9 and COQ10 were measured by high performance liquid chromatography with electrochemical detection. Findings: COQ9 represented approximately 91% of the total myocardial COQ pool in all groups. Compared to S, total COQ9 was decreased 30.0% in S+ST and 23.8% in E+ST (P<0.05). Approximately 56% of COQ9 was in reduced form in all groups; whereas COQ10 was more reduced (P<0.05) in the statin-treated groups. Exercise training resulted in similar increases (P<0.05) in E and E+ST for cardiac hypertrophy, cardiac output, and external cardiac work. Furthermore, myocardial oxygen consumption was coupled to ATP demand similarly in all groups. Conclusion & Significance: The magnitude of COQ decrease by simvastatin treatment is not sufficient to affect mitochondrial oxidative phosphorylation, cardiac function or the ability of the heart to adapt to the challenge of exercise training. COQ supplementation is not necessary.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Nutrition & Food Sciences.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Nutrition & Food Sciences
  • SubjectNutrition & Food Science
  • BylineArticles whose byline prints “Joseph W Starnes”
  • BylineArticles whose byline prints “Bryan J Feger”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels